The news is by your side.


Big pharma, big data: why drugmakers want your health records

LONDON: Drugmakers are racing to scoop up patient health records and strike deals with technology companies as big data analytics start to unlock a trove of information about how medicines perform in the real world. Studying such real-world evidence offers manufacturers a powerful tool to prove the value of their drugs - something Roche aims to leverage, for example, with last month’s $2 billion purchase of Flatiron Health. Real-world evidence involves collecting data outside traditional randomized clinical trials, the…

Trump pushes drugmakers for lower prices, more U.S. production

WASHINGTON/LOS ANGELES: U.S. President Donald Trump on Tuesday met with top executives from some of the biggest drugmakers, calling on them to boost U.S. production and lower prices, while he also promised to speed up approval times for new medicines. Trump reiterated that the government was paying too much for medicines in its health programs for older, disabled and poor people and said he would soon appoint a new U.S. Food and Drug Administration leader. At the same time, the meeting between Trump and the…